Study Suggests Pharmaceutical LSD Dose Could Alleviate Severe Anxiety for Weeks
AI-Generated Summary
A phase 2b study has indicated that a 100-microgram dose of MM120, a pharmaceutical version of LSD, may significantly reduce symptoms of generalised anxiety disorder (GAD) for up to 12 weeks. The trial, led by MindMed and published in JAMA, involved nearly 200 patients and found the therapeutic benefit was evident from day one. Most participants experienced mild, temporary hallucinations on dosing day, which resolved within 12 hours.
In a nutshell
This research offers a promising new avenue for treating GAD, a common condition often managed with talking therapies or SSRIs. If further phase 3 trials confirm these findings, MM120 could represent a novel, long-acting therapeutic option, potentially transforming mental health treatment approaches.
Source: RTE.ie
